176 related articles for article (PubMed ID: 37404599)
21. Histologic analysis of medication-related osteonecrosis of the jaw compared with antiresorptive-exposed bone and other infectious, inflammatory, and necrotic jaw diseases.
Yuan A; Munz A; Reinert S; Hoefert S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Feb; 129(2):133-140. PubMed ID: 31606424
[TBL] [Abstract][Full Text] [Related]
22. Incidence and risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease.
Fujieda Y; Doi M; Asaka T; Ota M; Hisada R; Ohnishi N; Kono M; Kameda H; Nakazawa D; Kato M; Amengual O; Takahata M; Yasuda S; Kitagawa Y; Atsumi T
J Bone Miner Metab; 2020 Jul; 38(4):581-588. PubMed ID: 32076874
[TBL] [Abstract][Full Text] [Related]
23. [Incidence of Antiresorptive Agent-Related Osteonecrosis of the Jaw in Urologic Cancers].
Kawanishi H; Yokozeki H; Hoshiyama A; Watanabe H; Funahashi Y; Fujiwara M; Takashima Y; Shintani M; Yui S; Okumura K
Hinyokika Kiyo; 2022 Jan; 68(1):1-6. PubMed ID: 35114759
[TBL] [Abstract][Full Text] [Related]
24. Antiresorptive agent-related osteonecrosis of the jaw in prostate cancer patients with bone metastasis treated with bone-modifying agents.
Nakai Y; Kanaki T; Yamamoto A; Tanaka R; Yamamoto Y; Nagahara A; Nakayama M; Kakimoto KI; Ishibashi M; Nishimura K
J Bone Miner Metab; 2021 Mar; 39(2):295-301. PubMed ID: 32886176
[TBL] [Abstract][Full Text] [Related]
25. Relationships of opacification in the nasal sinuses, rhinosinusitis, and antiresorptive agent-related osteonecrosis of the jaw.
Matsumoto Y; Yokoi H; Ikeda T; Kawada M; Saito K
Auris Nasus Larynx; 2020 Dec; 47(6):996-1002. PubMed ID: 32591168
[TBL] [Abstract][Full Text] [Related]
26. Dynamic polarization shifting from M1 to M2 macrophages in reduced osteonecrosis of the jaw-like lesions by cessation of anti-RANKL antibody in mice.
Tamaki S; Kuroshima S; Hayano H; Nakajima K; Kakehashi H; Ishisaki A; Sawase T
Bone; 2020 Dec; 141():115560. PubMed ID: 32730924
[TBL] [Abstract][Full Text] [Related]
27. Anti-VEGFR therapy is one of the healing inhibitors of antiresorptive-related osteonecrosis of the jaw.
Kanno C; Kaneko T; Endo M; Kitabatake T; Sakuma T; Kanaya Y; Watanabe Y; Hasegawa H
J Bone Miner Metab; 2021 May; 39(3):423-429. PubMed ID: 33196901
[TBL] [Abstract][Full Text] [Related]
28. Clinical course and therapeutic outcomes of operatively and non-operatively managed patients with denosumab-related osteonecrosis of the jaw (DRONJ).
Hoefert S; Yuan A; Munz A; Grimm M; Elayouti A; Reinert S
J Craniomaxillofac Surg; 2017 Apr; 45(4):570-578. PubMed ID: 28238559
[TBL] [Abstract][Full Text] [Related]
29. Antiresorptive agent-related osteonecrosis of the jaw (ARONJ) in urological malignancies: a multi-center retrospective study.
Sakai Y; Shindo T; Sato S; Takahashi A; Kunishima Y; Kato R; Itoh N; Okada M; Tachiki H; Taguchi K; Takayanagi A; Hotta H; Horita H; Matsukawa M; Matsuki M; Nishiyama K; Miyazaki A; Hashimoto K; Tanaka T; Masumori N
J Bone Miner Metab; 2021 Jul; 39(4):661-667. PubMed ID: 33704573
[TBL] [Abstract][Full Text] [Related]
30. Platelet rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw: personal experience and review of the literature.
Longo F; Guida A; Aversa C; Pavone E; Di Costanzo G; Ramaglia L; Ionna F
Int J Dent; 2014; 2014():298945. PubMed ID: 25013411
[TBL] [Abstract][Full Text] [Related]
31. Incidence and Risk of Anti-Resorptive Agent-Related Osteonecrosis of the Jaw after Tooth Extraction: A Retrospective Study.
Shimizu R; Sukegawa S; Sukegawa Y; Hasegawa K; Ono S; Nakamura T; Fujimura A; Fujisawa A; Nakano K; Takabatake K; Kawai H; Nagatsuka H; Furuki Y
Healthcare (Basel); 2022 Jul; 10(7):. PubMed ID: 35885858
[TBL] [Abstract][Full Text] [Related]
32. Denosumab-associated jaw bone necrosis in cancer patients: retrospective descriptive case series study.
Kang JY; Kim SY; Lim JS; Kim JY; Jin GY; Lee YJ; Lee EY
Maxillofac Plast Reconstr Surg; 2023 Jun; 45(1):23. PubMed ID: 37389685
[TBL] [Abstract][Full Text] [Related]
33. Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons.
Yoneda T; Hagino H; Sugimoto T; Ohta H; Takahashi S; Soen S; Taguchi A; Toyosawa S; Nagata T; Urade M
J Bone Miner Metab; 2010 Jul; 28(4):365-83. PubMed ID: 20333419
[TBL] [Abstract][Full Text] [Related]
34. Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab VS. zoledronic acid: A systematic review and meta-analysis.
Limones A; Sáez-Alcaide LM; Díaz-Parreño SA; Helm A; Bornstein MM; Molinero-Mourelle P
Med Oral Patol Oral Cir Bucal; 2020 May; 25(3):e326-e336. PubMed ID: 32271321
[TBL] [Abstract][Full Text] [Related]
35. A Retrospective Observational Study of Risk Factors for Denosumab-Related Osteonecrosis of the Jaw in Patients with Bone Metastases from Solid Cancers.
Okuma S; Matsuda Y; Nariai Y; Karino M; Suzuki R; Kanno T
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32408510
[TBL] [Abstract][Full Text] [Related]
36. National Survey on Bisphosphonate-Related Osteonecrosis of the Jaws in Japan.
Shibahara T; Morikawa T; Yago K; Kishimoto H; Imai Y; Kurita K
J Oral Maxillofac Surg; 2018 Oct; 76(10):2105-2112. PubMed ID: 29746838
[TBL] [Abstract][Full Text] [Related]
37. Clinical risk factors for severity and prognosis of antiresorptive agent-related osteonecrosis of the jaw: a retrospective observational study.
Nashi M; Hirai T; Iwamoto T; Takenobu T
J Bone Miner Metab; 2022 Nov; 40(6):1014-1020. PubMed ID: 36166107
[TBL] [Abstract][Full Text] [Related]
38. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
[TBL] [Abstract][Full Text] [Related]
39. Oral bisphosphonate-related osteonecrosis of the jaw: the first report in Asia.
Hong JW; Nam W; Cha IH; Chung SW; Choi HS; Kim KM; Kim KJ; Rhee Y; Lim SK
Osteoporos Int; 2010 May; 21(5):847-53. PubMed ID: 19633881
[TBL] [Abstract][Full Text] [Related]
40. Osteonecrosis of the jaw and nonmalignant disease: is there an association with rheumatoid arthritis?
Lescaille G; Coudert AE; Baaroun V; Javelot MJ; Cohen-Solal M; Berdal A; Goudot P; Azérad J; Ruhin B; Descroix V
J Rheumatol; 2013 Jun; 40(6):781-6. PubMed ID: 23504384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
